Wellington Management Company »

Contineum Therapeutics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $726k 56k 13.06

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Johnson & Johnson (JNJ)
Astrazeneca Ord (AZN)
Sempra Energy (SRE)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wellington Management Company

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Sectoral Asset Management

View all funds holding Contineum Therapeutics